South Cone Investments Limited Partnership - Net Worth and Insider Trading

South Cone Investments Limited Partnership Net Worth

The estimated net worth of South Cone Investments Limited Partnership is at least $84 Million dollars as of 2024-05-01. South Cone Investments Limited Partnership is the 10% Owner of Rani Therapeutics Holdings Inc and owns about 12,131,554 shares of Rani Therapeutics Holdings Inc (RANI) stock worth over $77 Million. South Cone Investments Limited Partnership is also the 10% Owner of FTC Solar Inc and owns about 14,867,592 shares of FTC Solar Inc (FTCI) stock worth over $7 Million. Details can be seen in South Cone Investments Limited Partnership's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that South Cone Investments Limited Partnership has not made any transactions after 2023-11-24 and currently still holds the listed stock(s).

Transaction Summary of South Cone Investments Limited Partnership

To

South Cone Investments Limited Partnership Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, South Cone Investments Limited Partnership owns 2 companies in total, including Rani Therapeutics Holdings Inc (RANI) , and FTC Solar Inc (FTCI) .

Click here to see the complete history of South Cone Investments Limited Partnership’s form 4 insider trades.

Insider Ownership Summary of South Cone Investments Limited Partnership

Ticker Comapny Transaction Date Type of Owner
RANI Rani Therapeutics Holdings Inc 2023-11-24 10 percent owner
FTCI FTC Solar Inc 2022-12-14 10 percent owner

South Cone Investments Limited Partnership Latest Holdings Summary

South Cone Investments Limited Partnership currently owns a total of 2 stocks. Among these stocks, South Cone Investments Limited Partnership owns 12,131,554 shares of Rani Therapeutics Holdings Inc (RANI) as of November 24, 2023, with a value of $77 Million and a weighting of 91.86%. South Cone Investments Limited Partnership also owns 14,867,592 shares of FTC Solar Inc (FTCI) as of December 14, 2022, with a value of $7 Million and a weighting of 8.14%.

Latest Holdings of South Cone Investments Limited Partnership

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RANI Rani Therapeutics Holdings Inc 2023-11-24 12,131,554 6.36 77,156,683
FTCI FTC Solar Inc 2022-12-14 14,867,592 0.46 6,839,092

Holding Weightings of South Cone Investments Limited Partnership


South Cone Investments Limited Partnership Form 4 Trading Tracker

According to the SEC Form 4 filings, South Cone Investments Limited Partnership has made a total of 32 transactions in Rani Therapeutics Holdings Inc (RANI) over the past 5 years, including 32 buys and 0 sells. The most-recent trade in Rani Therapeutics Holdings Inc is the acquisition of 5,265,165 shares on November 24, 2023, which cost South Cone Investments Limited Partnership around $11 Million.

According to the SEC Form 4 filings, South Cone Investments Limited Partnership has made a total of 4 transactions in FTC Solar Inc (FTCI) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in FTC Solar Inc is the acquisition of 41,962 shares on December 14, 2022, which cost South Cone Investments Limited Partnership around $114,137.

Insider Trading History of South Cone Investments Limited Partnership

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

South Cone Investments Limited Partnership Trading Performance

GuruFocus tracks the stock performance after each of South Cone Investments Limited Partnership's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by South Cone Investments Limited Partnership is -13.05%. GuruFocus also compares South Cone Investments Limited Partnership's trading performance to market benchmark return within the same time period. The performance of stocks bought by South Cone Investments Limited Partnership within 3 months outperforms 4 times out of 36 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how South Cone Investments Limited Partnership's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of South Cone Investments Limited Partnership

Average Return

-36.38%

Average return per transaction

Outperforming Transactions

21%

7 out of 33 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -8.22 -13.05 -42.96 -36.38
Relative Return to S&P 500(%) -8.86 -18.3 -50.27 -58.48

South Cone Investments Limited Partnership Ownership Network

Ownership Network List of South Cone Investments Limited Partnership

No Data

Ownership Network Relation of South Cone Investments Limited Partnership


South Cone Investments Limited Partnership Owned Company Details

What does Rani Therapeutics Holdings Inc do?

Who are the key executives at Rani Therapeutics Holdings Inc?

South Cone Investments Limited Partnership is the 10 percent owner of Rani Therapeutics Holdings Inc. Other key executives at Rani Therapeutics Holdings Inc include director & CEO Talat Imran , 10 percent owner Quiroga Cortes Isidoro Alfonso , and CHIEF BUSINESS OFFICER Kate Mckinley .

Rani Therapeutics Holdings Inc (RANI) Insider Trades Summary

Over the past 18 months, South Cone Investments Limited Partnership made 32 insider transaction in Rani Therapeutics Holdings Inc (RANI) with a net purchase of 5,555,528. Other recent insider transactions involving Rani Therapeutics Holdings Inc (RANI) include a net sale of 5,158,997 shares made by Quiroga Cortes Isidoro Alfonso , a net purchase of 40,000 shares made by Talat Imran , and a net purchase of 50,500 shares made by Jean Luc Butel .

In summary, during the past 3 months, insiders sold 0 shares of Rani Therapeutics Holdings Inc (RANI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 5,265,165 shares of Rani Therapeutics Holdings Inc (RANI) were sold and 5,752,696 shares were bought by its insiders, resulting in a net purchase of 487,531 shares.

Rani Therapeutics Holdings Inc (RANI)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Rani Therapeutics Holdings Inc Insider Transactions

No Available Data

South Cone Investments Limited Partnership Mailing Address

Above is the net worth, insider trading, and ownership report for South Cone Investments Limited Partnership. You might contact South Cone Investments Limited Partnership via mailing address: Avenida Presidente Riesco 5711 Oficina 1, Las Condes, Santiago F3 7550000.

Discussions on South Cone Investments Limited Partnership

No discussions yet.